Life ScienceCompany
Bristol-Myers - HIV R&D portfolio Ownership
Who owns Bristol-Myers - HIV R&D portfolio?
Bristol-Myers - HIV R&D portfolio is owned by ViiV Healthcare. It was acquired on February 22, 2016.
Bristol-Myers - HIV R&D portfolio Business Overview
Where is Bristol-Myers - HIV R&D portfolio headquartered?
Bristol-Myers - HIV R&D portfolio is headquartered in United States.
What sector is Bristol-Myers - HIV R&D portfolio in?
Bristol-Myers - HIV R&D portfolio is a life science company.
Life Science M&A Summary in 2016
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.
Join Mergr to view all 296 acquisitions of life science companies in 2016, including 34 acquisitions by private equity firms, and 262 by strategics.